Article Details

HOME / ARCHIVES / Vol. 3 No. 4 : April (2021) / Popular Article

A Discussion on Second Wave of COVID-19 Pandemic in India

Jyoti Prakash Sahoo^*

Dept. of Agricultural Biotechnology, Odisha University of Agriculture and Technology, Bhubaneswar, Odisha (751 003), India

Lipi Ghosh

School of Development Studies, Tata Institute of Social Sciences, Mumbai, Maharashtra (400 088), India

Kailash Chandra Samal

Dept. of Agricultural Biotechnology, Odisha University of Agriculture and Technology, Bhubaneswar, Odisha (751 003), India

DOI: NIL

Keywords: COVID-19, India, Second wave, Vaccines

Abstract

In India, a new double mutant strain of the SARS-CoV-2 virus has been discovered. The new virus strain, which contains two mutations, is highly infectious and has the ability to bypass immunity acquired by natural infection or vaccination. The development raises significant concerns for the nation, as a second wave of the COVID-19 pandemic looms large in a country where over 50 million people have already been vaccinated against the disease. The fraction of samples with the E484Q and L452R mutations has increased in Maharashtra, India, compared to December 2020, according to an examination of samples from the state. India has administered more than 100 million doses of the COVID-19 vaccine as of April 10, making it the fastest country to do so. The vaccine can now be administered in private sector facilities as well. This necessitates a high degree of planning and readiness at each centre.